Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902219-24-000424
Filing Date
2024-11-08
Accepted
2024-11-08 10:41:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G 29743
2 JOINT FILING AGREEMENT Rule13D_JointFilingAgreement.htm EX-99 4391
  Complete submission text file 0000902219-24-000424.txt   36370
Mailing Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210
Business Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210 6179515000
WELLINGTON MANAGEMENT GROUP LLP (Filed by) CIK: 0000902219 (see all company filings)

EIN.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Subject) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-78541 | Film No.: 241438568
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)